The key idea is that clinical importance comes from a result that patients value and that changes real-life outcomes in a meaningful way. It isn’t enough for an effect to be detectable in a study or statistically unlikely to be due to chance; it must matter to the patient and be large enough to make a real difference in daily life or health status. That’s why the best choice says the change has value to the patient and is large enough to affect a patient’s life. If a result patients don’t perceive as beneficial or that doesn’t translate into noticeable improvements in their health or functioning, it won’t be clinically important, even if the statistics look solid. Conversely, an effect that patients value and that meaningfully improves outcomes is what clinicians and stakeholders consider clinically important. The other options mix statistical significance, magnitude, practicality, or regulatory approval. A result can be statistically significant without being meaningful to patients, a large effect size alone doesn’t guarantee patient-perceived benefit, and cost, ease of implementation, or regulatory approval don’t by themselves establish clinical importance.

Data cleaning is the process of identifying and correcting errors, handling missing values, and resolving inconsistencies in a dataset before analysis. This step is essential because errors, gaps, and conflicting information can distort results, lead to biased conclusions, and undermine the reliability of any model or decision based on the data. By cleaning the data, you ensure that analyses reflect true patterns rather than artifacts of messy data, which improves accuracy and trust in findings. The option describing identifying and correcting errors, missing values, and inconsistencies best captures this preparation. Collecting more data doesn’t fix quality issues, removing all missing values can waste information or bias results, and analyzing without processing skips necessary quality checks.

Random assignment directly targets confounding from pre-existing differences between groups. By randomly assigning participants to conditions, the groups become, on average, similar in both measured and unmeasured characteristics before the intervention. This means that any observed effect is more likely due to the experimental manipulation itself rather than pre-existing differences, which is the core threat to internal validity that randomization mitigating. Attrition bias from differential dropout isn’t guaranteed to be prevented by random assignment, though it can be mitigated with good retention efforts and analysis strategies. Instrumentation drift across measurements relates to changes in measurement tools or procedures over time, which isn’t solved by how participants are allocated to groups. Demand characteristics stem from participants’ guesses about the study aims and can influence behavior regardless of assignment; randomization doesn’t inherently fix that.

Power is the study’s ability to detect a real difference when one exists. A smaller sample reduces power because it increases sampling variability and leads to wider confidence intervals. With less power, a true difference is less likely to be found, which is described as the study being underpowered. This also means a higher risk of a Type II error—failing to reject the null when there is a real effect. An overpowered study would have more power than needed and could detect even tiny differences. An unbiased study refers to absence of systematic error, not the ability to detect differences. A representative sample concerns how well the sample mirrors the population, not the study’s power.